Neurognos

📍 Providencia, Chile🗓 Founded 2016💰 Last funded Jun 2021
Biotechnology Research🌐 neurognos.com
Website LinkedIn
Our mission is to make Alzheimers and other neurodegenerative disease detection accessible to people everywhere in the world even before the first symptoms arise, enabling early intervention of diseases and empowering doctors and patient. At Neurognos we are working to change the outcome of Alzheimer’s disease by providing the right information at the right time. We are aiming to do this with our proprietary technology that let us identify the early indications of the disease even years before the first cognitives symptoms are detectable. To ensure the quality and reliability of our results we are working with CLIA-certified laboratories, standardizing our procedures, automating our operations and systematizing our controls. All this just to offer the highest levels of precision possible.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Chile
1
Frequently asked questions
Who invested in Neurognos?
Neurognos has 1 investors on record on gritt.io, 1 mid-stage.
When did Neurognos last raise funding?
The most recent investment in Neurognos recorded on gritt.io was in June 2021.
When was Neurognos founded?
Neurognos was founded in 2016.
What industry is Neurognos in?
Neurognos operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Neurognos based?
Neurognos is headquartered in Providencia, Chile.